BCIQ Profiles

Company Profile Report

Arix leads Iterum's $65M series B

Anti-infective play Iterum Therapeutics Ltd. (Dublin, Ireland) raised $65 million in an oversubscribed series B led by new investor Arix Bioscience plc (LSE:ARIX). New investors Pivotal bioVenture Partners,

Read the full 281 word article

How to gain access

Continue reading with a
two-week free trial.